D
Inhibikase Therapeutics, Inc. IKT
$2.42 $0.05252.22%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -25.74% 14.16% -3.84% 2.36% -2.24%
Total Depreciation and Amortization 0.00% -95.85% 32.00% 32.00% 288.24%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 0.61% -75.40% -56.69% 71.70% 19.98%
Change in Net Operating Assets 120.62% -114.22% 144.53% -7.16% 129.66%
Cash from Operations -18.90% -10.71% 35.25% 3.21% 25.43%
Capital Expenditure -- -- -- -- 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -85.19% -0.82% 43.28% -142.63% 182.32%
Cash from Investing -85.19% -0.26% 43.28% -142.63% 181.53%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 181,900.00% -- -95.37% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 181,900.00% 9,111.94% -95.72% -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -116.77% 135.73% -110.77% -504.96% 149.02%
Weiss Ratings